What is a Rule 10b5-1 trading plan?

A Rule 10b5-1 trading plan is a pre-arranged plan for buying or selling company stock. It allows individuals, such as corporate executives, to trade company securities at a time when they might not be in possession of material non-public information. This helps diversify portfolios and avoid potential insider trading concerns.

Why is Cigna's CEO adopting this plan now?

The options granted in 2011, 2012, and 2013 are nearing their ten-year expiration date. The 10b5-1 plan provides a structured way for Mr. Cordani to exercise these options and manage the subsequent sale of shares, including covering the costs associated with the exercise, within regulatory guidelines.

Will this plan impact Mr. Cordani's ownership of Cigna stock?

According to the filing, Mr. Cordani does not expect the plan to materially change his overall ownership position. He remains subject to Cigna's executive stock ownership guidelines, which require him to hold stock and stock equivalents valued at least eight times his base salary.

Does this indicate any negative outlook for Cigna's stock?

No, the adoption of a 10b5-1 plan is a standard practice for executives for personal financial planning and diversification. It is designed to allow stock transactions during periods when executives might otherwise be restricted from trading due to potential insider information. This filing does not suggest a negative outlook on the company's performance.

CI 8-K SEC Disclosure — Dec 27, 2019

Summary

Cigna Group (CI) announced on December 27, 2019, that its President and CEO, David M. Cordani, has adopted a stock trading plan designed to comply with Rule 10b5-1 of the Securities Exchange Act of 1934. This plan allows for the pre-arranged exercise of stock options and sale of shares over a specified period, enabling diversification and financial planning while adhering to regulations that prevent trading on material non-public information. The plan outlines the exercise of a significant number of stock options granted in 2011, 2012, and 2013, which are approaching their ten-year expiration. It also includes the sale of shares acquired through option exercises, covering exercise prices, taxes, and fees, as well as shares from the company's strategic performance share program. Mr. Cordani will not have discretion over these transactions once the plan is in effect. This action is expected to have no material impact on his overall stock ownership position, as he remains subject to the company's executive stock ownership guidelines.

Key Highlights

1CEO David M. Cordani has adopted a Rule 10b5-1 stock trading plan.
2The plan covers the exercise of stock options granted in 2011, 2012, and 2013, which expire after ten years.
3Transactions are scheduled to occur between March 2020 and February 2021.
4The plan allows for the sale of shares to cover option exercise costs, taxes, and fees.
5Shares from the company's strategic performance share program will also be sold under the plan.
6Mr. Cordani will not have discretion over transactions once the plan is active.
7The plan is not expected to materially change Mr. Cordani's overall stock ownership.

Cigna Group 8-K Report, Corporate Update (Dec 27, 2019)

Summary

Key Highlights

Frequently Asked Questions